RNS Number : 0779L
16 April 2018
("Ergomed" or the "Company")
Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 16 April 2018, Dr Miroslav Reljanovic, founder and Executive Vice-Chairman of the Company, sold 4,000,000 ordinary shares of 1p each in the Company ("Share(s)") at a price of 190p per Share to meet institutional demand.
Following this transaction, Dr Miroslav Reljanovic's holding has reduced to 11,132,237 shares (representing 24.9 per cent. of the Company's issued share capital).
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
This information is provided by RNS
The company news service from the London Stock Exchange
Pumpedordumped cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk. Thankyou.